XForceGlobal

Alibaba: Potential Correction before a Breakout 1D (Apr. 27)

NYSE:BABA   Alibaba Group Holdings Ltd.
X FORCE GLOBAL ANALYSIS:


Alibaba has shown a strong recovery after having locally bottomed due to the Corona Virus (Covid-19). Despite being a Chinese company, the e-commerce giant has not been as severely affected by the gravity of the situation. In this analysis, we take a look at Alibaba's (BABA) technicals and fundamentals to determine the most probable scenario.

Technical analysis

- We have been rejected by the descending trend line resistance marked in the dotted blue line
- The Relative Strength Index (RSI) shows a downtrend, with the formation of lower highs
- The Moving Average Convergence Divergence (MACD) shows decreasing bullish histograms, and a potential death cross
- We are seeing a temporary trend reversal to potentially fill the gaps below

Fundamental analysis

- The Corona Virus has impacted the company as fewer people were able to produce and deliver to their customers
- While supply issues have been handled now, there are now questions about how consumer demand for e-commerce products is holding up amid a period of global economic uncertainty and continued unease about germ spread
- Despite the confusion caused by the Corona Virus (COVID-19), Alibaba continues to invest aggressively into Alibaba Cloud
- As governments aggressively digitize services, cloud demand will be stimulated, and it's likely that Alibaba will be one of the beneficiaries

What We Believe

We believe that Alibaba is a strong company to hold for the long term. Alibaba shows strong fundamentals, and aggressive investments for the future that appear prudent. However, technical analysis demonstrates that we could be seeing a small correction for the immediate term.

Trade Safe.

🌎 Telegram | t.me/xforceglobal

📢 Twitter | twitter.com/XForceGlobal

▶️ Youtube | www.youtube.com/c/xforceglobal
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.